APRT belongs to the Type I Phosphoribosyltransferase (PRTase) family . The enzyme catalyzes the transfer of a phosphoribosyl group from phosphoribosyl pyrophosphate (PRPP) to adenine, forming adenosine monophosphate (AMP) and pyrophosphate (PPi) . The reaction can be summarized as follows:
This reaction is vital for the nucleotide salvage pathway, providing an alternative to the energetically expensive de novo synthesis of nucleotides .
APRT deficiency can lead to serious kidney conditions, including nephrolithiasis (kidney stones), interstitial nephritis, and chronic renal failure . This is due to the precipitation of 2,8-dihydroxyadenine (DHA) crystals in the renal interstitium . Understanding the structure and function of APRT is crucial for developing treatments for these conditions.
Human recombinant APRT is produced using Escherichia coli as an expression system . The recombinant enzyme has been crystallized and studied using X-ray diffraction, revealing a structure composed of nine beta-strands and six alpha-helices . The active site pocket of APRT opens slightly to accommodate the AMP product, and structural comparisons with other PRTases have provided insights into the enzyme’s specificity and function .